Literature DB >> 7654645

Perineoplasty compared with vestibuloplasty for severe vulvar vestibulitis.

J Bornstein1, D Zarfati, Z Goldik, H Abramovici.   

Abstract

OBJECTIVE: To evaluate the efficacy of vestibuloplasty (vestibular undercutting without excision) to treat severe vulvar vestibulitis.
DESIGN: Prospective randomisation of patients scheduled for surgery to undergo either perineoplasty or vestibuloplasty. Differences in outcome between groups were analysed using Fisher's exact test.
SETTING: The Vulvar Clinic and referral centre for vestibulitis, Kupath Holim Health System, Department of Obstetrics and Gynaecology, Carmel Medical Centre, Rapapport Faculty of Medicine, Hatechnion, Haifa, Israel.
SUBJECTS: Twenty-one women with vulvar vestibulitis.
RESULTS: Vestibuloplasty failed to relieve symptoms in 10 women, while perineoplasty resulted in complete resolution of symptoms in 9/11 women (P < 0.002).
CONCLUSIONS: The poor outcome of vestibuloplasty, if also reported by other centres, may render it an unacceptable treatment for vulvar vestibulitis. Vestibuloplasty aims to denervate sensitive vestibular tissue, and its failure may suggest that innervation disturbances are not the main cause of the syndrome.

Entities:  

Mesh:

Year:  1995        PMID: 7654645     DOI: 10.1111/j.1471-0528.1995.tb11405.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  4 in total

1.  Psychological and psychosexual aspects of vulvar vestibulitis.

Authors:  D Nunns; D Mandal
Journal:  Genitourin Med       Date:  1997-12

2.  Recruitment methods in a clinical trial of provoked vulvodynia: Predictors of enrollment.

Authors:  Candi C Bachour; Gloria A Bachmann; David C Foster; Jim Y Wan; Leslie A Rawlinson; Candace S Brown
Journal:  Clin Trials       Date:  2016-08-11       Impact factor: 2.486

3.  Vulvar vestibulitis syndrome.

Authors:  Carolyn Gardella
Journal:  Curr Infect Dis Rep       Date:  2006-11       Impact factor: 3.663

Review 4.  Surgical treatment for chronic pelvic pain.

Authors:  J E Carter
Journal:  JSLS       Date:  1998 Apr-Jun       Impact factor: 2.172

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.